A. Arntz et al., OPIOID ANTAGONIST AFFECTS BEHAVIORAL-EFFECTS OF EXPOSURE IN-VIVO, Journal of consulting and clinical psychology, 61(5), 1993, pp. 865-870
This study tested the hypothesis that endogenous opioids are involved
in the extinction of phobic fear through exposure in vivo. Forty-eight
spider phobics participated in a 2-hr therapist-directed exposure in
vivo treatment. Sixteen Ss were assigned to placebo, 16 to a low dose
of naltrexone, and 16 to a high dose of naltrexone. Before interventio
n, after treatment, and at a 1-wk follow-up test, self-report, physiol
ogical, and behavioral measures of phobic fear were completed. At 1-wk
follow-up, naltrexone was significantly related, in a dose-dependent
way, to a greater relapse on avoidance measures but not on emotional,
cognitive, and physiological measures. Endogenous opioids may be speci
fically involved in the extinction of avoidance behavior but not in th
e extinction of all aspects of phobic fear.